23andMe could get delisted from the Nasdaq after all 7 members of its board resigned this week. CEO Anne Wojcicki is a big name in Silicon Valley but has struggled to find a sustainable business model and shares are 99% off its peak valuation post-SPAC merger. Wojcicki is now hoping to pivot and take the company private by buying back all outstanding shares in what could be seen as a “founders mode” leadership move.
